This functionality is implemented using Javascript. It cannot work without it, etc...

Estamos cargando la información...

Saltar al contenido

Progenitor Cell Therapy for the Treatment of Damaged Myocardium due to Ischemia

Progenitor cell therapy, including but not limited to skeletal myoblasts or hematopoietic cells, is considered investigational as a treatment of damaged myocardium.
Infusion of growth factors (ie, granulocyte colony stimulating factor) is considered investigational as a technique to increase the numbers of circulating hematopoietic cells as treatment of damaged myocardium.

787-277-6653 787-474-6326